Menu

Details of First Three-Parent IVF Revealed

The team that oversaw the first use of mitochondrial replacement therapy that resulted in a live birth has published an account of the procedure.

Apr 3, 2017
Bob Grant

John Zhang with the baby that was the first ever to be born after mitochondrial replacement therapyIMAGE COURTESY OF NEW HOPE FERTILITY CLINICLast year, a Jordanian couple became parents to the world’s first-ever baby born through a controversial in vitro fertilization (IVF) technique called mitochondrial replacement therapy (MRT). Now, the doctors who performed the procedure, which involves inserting nuclei from the mothers’ egg cells and into donor ova with health mitochondria, have revealed more detail on the conception and resulting live birth. 

John Zhang of the New Hope Fertility Center in New York City and colleagues published an account of the treatment in this month’s issue of Reproductive BioMedicine Online. “Certainly, this is a landmark study,” Dietrich Egli, a stem cell researcher at the New York Stem Cell Foundation, told Nature.

Zhang and colleagues revealed that the mother of the baby boy is a carrier of Lehigh disease, a rare neurometabolic disorder that decimates a child’s muscular system and often results in respiratory failure and death. The authors also described the IVF procedure, including the method they used to transfer the mother’s egg cell nuclei into the donor egg cells. They froze and heated the embryo and then fused the mother’s nuclei into donor ova using an electrical pulse.

In their paper, the researchers also reported that the child carried a 2.36 percent to 9.23 percent mitochondrial DNA (mtDNA) mutational load in samples tested (including hair follicles, circumcised foreskin, and umbilical blood). Because some mutated mtDNA slipped into the embryo, the child may suffer health problems later in life, the authors wrote.

The parents of the child told Zhang and colleagues that they would forgo any mitochondrial testing in their son unless it becomes medically necessary.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!